Target intelligence / Profile preview

Vitamin K-dependent gamma-glutamyl carboxylation system (VKCS) (VKCS)

Target
VKCS
Molecular classification
Enzyme, Oxidoreductase, Transferase
01

Overview

The Vitamin K-dependent carboxylation machinery is a multi-enzyme system responsible for the post-translational modification of specific proteins, primarily those involved in blood coagulation and bone metabolism (Tie & Stafford, 2016, Blood). The central reaction, catalyzed by gamma-glutamyl carboxylase (GGCX; UniProt P38435), converts glutamic acid residues into gamma-carboxyglutamic acid (Gla) residues, which allows these proteins to bind calcium ions (Oldenburg et al., 2008, J Thromb Haemost). This process requires the reduced form of Vitamin K (hydroquinone) as a cofactor, which is subsequently regenerated from Vitamin K epoxide by the enzyme Vitamin K epoxide reductase (VKORC1; UniProt Q9BQB6). Dysregulation or inhibition of this machinery leads to the production of undercarboxylated, non-functional proteins, a mechanism exploited by anticoagulant drugs like warfarin to prevent thrombosis (StatPearls, Warfarin). Beyond coagulation, this system plays critical roles in preventing vascular calcification and maintaining bone density through the activation of Matrix Gla Protein (MGP) and osteocalcin (Berkner, 2005, Vitamin K-dependent Carboxylation).

Other names
Vitamin K cycleVitamin K-dependent carboxylation machineryGamma-carboxylation systemVitamin K-dependent gamma-glutamyl carboxylase complex
02

Mechanism of action

Inhibition of Vitamin K epoxide reductase (VKORC1) to deplete the pool of reduced Vitamin K, thereby preventing the gamma-carboxylation of Vitamin K-dependent proteins.

03

Biological functions

Post-translational modificationBlood coagulationBone mineralizationVascular calcification inhibition
04

Disease associations

ThrombosisVitamin K-dependent coagulation factor deficiency (VKCFD)OsteoporosisVascular calcificationPseudoxanthoma elasticum-like syndrome
05

Safety considerations

Risk of major hemorrhageWarfarin-induced skin necrosisTeratogenicity (Warfarin embryopathy)Narrow therapeutic indexDrug-food interactions with Vitamin K-rich foods
06

Interacting drugs

Warfarin

5 more in the full profile.

07

Biomarkers

International Normalized Ratio (INR)Prothrombin time (PT)PIVKA-II (Protein Induced by Vitamin K Absence/Antagonist-II)Undercarboxylated osteocalcin (ucOC)

Beyond the preview

Go deeper on Vitamin K-dependent gamma-glutamyl carboxylation system (VKCS) (VKCS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitamin K-dependent gamma-glutamyl carboxylation system (VKCS) (VKCS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call